LOGO.png
Nemaura Medical Announces Progress on Listing of sugarBEAT® For Reimbursement in Germany
May 06, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, May 06, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors
May 05, 2021 08:00 ET | Nemaura Medical, Inc
Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches in Germany, Saudi Arabia and UAE Loughborough, England, May 05, 2021 (GLOBE...
LOGO.png
Nemaura Medical to Participate at the Benzinga Global Small Cap Conference and Present to Investors on May 14, 2021
May 04, 2021 16:10 ET | Nemaura Medical, Inc
Loughborough, England, May 04, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic...
LOGO.png
Nemaura Medical Issues Letter to Shareholders Following April 28 Shareholder Update Call
April 29, 2021 08:04 ET | Nemaura Medical, Inc
Loughborough, England, April 29, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical to Conduct Shareholder Update Call April 28, 2021, 4:30PM ET
April 21, 2021 08:10 ET | Nemaura Medical, Inc
Loughborough, England, April 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Appoints Samantha Sanders as Global Head of Digital Programs
April 15, 2021 08:07 ET | Nemaura Medical, Inc
Loughborough, England, April 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Launches BEAT®diabetes Smartphone App on Android and iOS Platforms; Begins Pilot Distribution of proBEAT™ Sensors
April 13, 2021 08:05 ET | Nemaura Medical, Inc
Loughborough, England, April 13, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Retains Paul Kennedy as Advisor for International Growth Opportunities and Member of the Executive Advisory Board
March 25, 2021 08:10 ET | Nemaura Medical, Inc
Loughborough, England, March 25, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical Announces Submission to German Authorities for Reimbursement of its Glucose Monitoring Device
March 11, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, March 11, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
LOGO.png
Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 10, 2021 08:00 ET | Nemaura Medical, Inc
Loughborough, England, March 10, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...